P

Inventor

BURKE MARTIN D

US39 patents
⚠️ This page may combine multiple inventors who share the name “BURKE MARTIN D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV ILLINOIS

28 patents
US8013203B2Sep 6, 2011

System for controlling the reactivity of boronic acids

UNIV ILLINOIS13 citations92
US10239824B2Mar 26, 2019

Automated synthesis of small molecules using chiral, non-racemic boronates

UNIV ILLINOIS1 citations72
US9738677B2Aug 22, 2017

Amphotericin B derivative with reduced toxicity

UNIV ILLINOIS4 citations71
US11117920B2Sep 14, 2021

Amphotericin B derivatives with improved therapeutic index

UNIV ILLINOIS1 citations70
US11028114B2Jun 8, 2021

Amphotericin B derivatives with improved therapeutic index

UNIV ILLINOIS1 citations70
US10323057B2Jun 18, 2019

Amphotericin B derivatives with improved therapeutic index

UNIV ILLINOIS3 citations70
US10087206B2Oct 2, 2018

Scalable synthesis of reduced toxicity derivative of amphotericin B

UNIV ILLINOIS2 citations69
US9845317B2Dec 19, 2017

Slow release of organoboronic acids in cross-coupling reactions

UNIV ILLINOIS1 citations62
US9328102B2May 3, 2016

Slow release of organoboronic acids in cross-coupling reactions

UNIV ILLINOIS2 citations62
US9006463B2Apr 14, 2015

Slow release of organoboronic acids in cross-coupling reactions

UNIV ILLINOIS3 citations62
US11970512B2Apr 30, 2024

Amphotericin B derivatives with improved therapeutic index

UNIV ILLINOIS0 citations60
US11850256B2Dec 26, 2023

Small molecule-mediated restoration of airway surface physiology in human cystic fibrosis lung epithelia

UNIV ILLINOIS1 citations56
US12090164B2Sep 17, 2024

Genotype-agnostic rescue of cystic fibrosis with small molecule bicarbonate channels

UNIV ILLINOIS1 citations54
US11517540B2Dec 6, 2022

Restoring physiology in iron-deficient organisms using small molecules

UNIV ILLINOIS0 citations54
US12419899B2Sep 23, 2025

Ion channel prosthetic compositions comprising lipid-coated crystals of amphotericin B

UNIV ILLINOIS0 citations53
US12084411B2Sep 10, 2024

Hinokitiol analogues, methods of preparing and pharmaceutical compositions thereof

UNIV ILLINOIS0 citations53
US11926877B2Mar 12, 2024

Saliva-based molecular testing for SARS-CoV-2

UNIV ILLINOIS0 citations53
US11530457B2Dec 20, 2022

Saliva-based molecular testing for SARS-CoV-2

UNIV ILLINOIS0 citations53
US9732102B2Aug 15, 2017

System for controlling the reactivity of boronic acids

UNIV ILLINOIS0 citations52
US9328127B2May 3, 2016

System for controlling the reactivity of boronic acids

UNIV ILLINOIS0 citations52
US10752577B2Aug 25, 2020

Automated synthesis of small molecules using chiral, non-racemic boronates

UNIV ILLINOIS0 citations51
US9388131B2Jul 12, 2016

Automated synthesis of small molecules using chiral, non-racemic boronates

UNIV ILLINOIS0 citations51
US10683318B2Jun 16, 2020

Scalable synthesis of reduced toxicity derivative of amphotericin B

UNIV ILLINOIS0 citations48
US9908900B2Mar 6, 2018

Methods for forming protected organoboronic acids

UNIV ILLINOIS0 citations48
US10072028B2Sep 11, 2018

Cross-coupling of unactivated secondary boronic acids

UNIV ILLINOIS0 citations46
US11198705B2Dec 14, 2021

Hybrid Amphotericin B derivatives with reduced toxicity

UNIV ILLINOIS0 citations44
US10370393B2Aug 6, 2019

Stereoretentive cross-coupling of boronic acids

UNIV ILLINOIS0 citations37
US10844081B2Nov 24, 2020

Protected organoboronic acids with tunable reactivity, and methods of use thereof

UNIV ILLINOIS0 citations31

BURKE MARTIN D

7 patents

SFUNGA THERAPEUTICS INC

2 patents

REVOLUTION MEDICINES INC

1 patent

RIGEL PHARMACEUTICALS INC

1 patent